BDO Wealth Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$38K Buy
174
+15
+9% +$3.34K ﹤0.01% 478
2023
Q1
$34.8K Hold
159
﹤0.01% 485
2022
Q4
$33.1K Hold
159
﹤0.01% 477
2022
Q3
$35K Hold
159
﹤0.01% 466
2022
Q2
$33K Hold
159
﹤0.01% 478
2022
Q1
$39K Hold
159
﹤0.01% 478
2021
Q4
$41K Hold
159
﹤0.01% 481
2021
Q3
$42K Hold
159
﹤0.01% 476
2021
Q2
$39K Sell
159
-13
-8% -$2.73K ﹤0.01% 499
2021
Q1
$33K Hold
172
﹤0.01% 522
2020
Q4
$37K Buy
172
+25
+17% +$4.99K 0.01% 385
2020
Q3
$25K Buy
147
+13
+10% +$2.4K ﹤0.01% 398
2020
Q2
$26K Hold
134
﹤0.01% 397
2020
Q1
$20K Hold
134
﹤0.01% 452
2019
Q4
$21K Hold
134
0.01% 384
2019
Q3
$18K Hold
134
﹤0.01% 407
2019
Q2
$16K Hold
134
﹤0.01% 407
2019
Q1
$14K Hold
134
﹤0.01% 400
2018
Q4
$15K Hold
134
0.01% 372
2018
Q3
$15K Hold
134
﹤0.01% 419
2018
Q2
$14K Hold
134
﹤0.01% 422
2018
Q1
$13K Hold
134
﹤0.01% 374
2017
Q4
$11K Hold
134
﹤0.01% 334
2017
Q3
$10K Hold
134
0.01% 311
2017
Q2
$10K Buy
+134
New +$9.59K ﹤0.01% 377

Other funds holding RMD

BDO Wealth Advisors's RMD Position: Q2 2023 in Review

BDO Wealth Advisors increased its ResMed (RMD) stake by 9.4% in Q2 2023, buying an estimated $3.34K and bringing the position to 174 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

BDO Wealth Advisors first reported a position in RMD in Q2 2017 and has held it in 25 quarters since. The position peaked at $42K in Q3 2021. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

  • BDO Wealth Advisors held 174 shares of ResMed worth $38K as of Q2 2023.
  • BDO Wealth Advisors bought 15 ResMed shares in Q2 2023, an estimated $3.34K.
  • ResMed made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #478 holding.
  • BDO Wealth Advisors first reported a position in ResMed in Q2 2017 and has held it in 25 quarters since.
  • BDO Wealth Advisors's ResMed position peaked at $42K in Q3 2021.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.